Form 4: MannKind Director Steven Binder Receives RSU Grant

Director Steven B. Binder was granted 82,781 restricted stock units by MannKind Corporation on May 20, 2026.

Summary

• Director Steven B. Binder acquired 82,781 restricted stock units (RSUs) on May 20, 2026.
• Each RSU represents a contingent right to receive one share of MannKind Corporation common stock.
• The RSUs vested immediately upon grant.
• Delivery of the underlying shares is deferred until the director separates from service on the board.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on the company's financial position.

Positives

• Alignment of director interests with long-term shareholder value through equity-based compensation.

Negatives

• None identified in this filing.

Risks

• Future share delivery is contingent upon the director's eventual separation from the board.

Future Outlook

The filing does not provide forward-looking financial guidance, focusing solely on director equity compensation.

Industry Context

StockSavvy.ai notes that equity grants to board members are standard corporate governance practice to ensure alignment between leadership and shareholders, particularly in the biotechnology sector where long-term development cycles are common.

Comparison to Industry Standards

• The use of deferred-delivery RSUs for board members is a common practice among mid-cap biotechnology firms to retain board talent and align incentives.
• The grant size is consistent with standard director compensation packages for companies of similar market capitalization.

Corporate Governance

Stakeholder Impact

• Shareholders: Minor dilution impact upon eventual share issuance.

Next Steps

• Delivery of common stock shares upon the director's future separation from the board.

Key Dates

Keywords

MannKind, MNKD, Form 4, Insider Trading, Restricted Stock Units, Director Compensation